Chimerism Post-Engraftment Analysis in UAE | 1100 AED | DHA Licensed

Executive Summary & Core Metrics

Executive Summary

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 certified laboratory processing, complying with UAE data protection and health information standards.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
Clinical Guidance: Complimentary telephonic post-test clinical correlation discussion with a DHA-licensed Consultant Medical Genetics to help interpret results responsibly.
Insurance: Direct billing verification via WhatsApp at +971 54 548 8731 for seamless claim processing.

Test Overview & Methodology

Chimerism post-engraftment analysis is a molecular diagnostic test that quantifies donor versus recipient hematopoietic cells after allogeneic stem cell or bone marrow transplantation. This test enables early detection of graft failure, disease relapse, and guides timely therapeutic intervention using high-sensitivity capillary electrophoresis.

Feature	Our Test	Closest Alternative
Methodology	Multiplex PCR-STR Fragment Analysis by Capillary Electrophoresis (CE)	Conventional STR-PCR without CE resolution or automated genotyping
Precision	99.9% sensitivity; detection limit 0.1% minor cell population	Lower sensitivity (~1%), may miss low-level mixed chimerism
Turnaround Time	7 working days, secure online report	Often 10–14 days, manual reporting
Home Collection	ISO-certified cold-chain VIP phlebotomy 8 AM–11 PM	Not available or non-refrigerated transfer

Physician Insight & Safety Protocols

“As a Consultant Medical Genetics specializing in post-transplant engraftment monitoring, I want you to know that chimerism analysis provides a quantifiable snapshot of donor cell contribution. This powerful tool aids early detection of graft loss or relapse, but it must be interpreted alongside clinical signs, blood counts, and other investigations. Never adjust immunosuppressive medications solely based on a lab result without consulting your transplant team.”

— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403

Clinical Advisory

Important Medication Guidance

Do not discontinue or adjust any prescribed immunosuppressive, antiviral, or other medication based solely on this test result. Always consult your transplant physician first.

Safety Exclusion Criteria & ER Red Flags

Exclusion criteria: Wrong tube type (must be EDTA lavender top), frozen specimen, inadequate volume (<2 mL), no documented date of bone marrow transplant.
Emergency red flags: If you experience sudden fever >38°C, severe drop in blood counts, new skin rash or diarrhea suggestive of acute GVHD, or unusual bleeding, seek immediate medical attention—do not wait for results.

Patient FAQ & Clinical Guidance

1. What is Chimerism Post-Engraftment Analysis, and why do I need it?

Chimerism post-engraftment analysis uses highly sensitive PCR-STR fragment analysis to measure the proportion of donor cells in your blood or bone marrow after a stem cell transplant, enabling early detection of graft loss or relapse before clinical symptoms appear.

2. How is the sample collected, and do you offer home service?

A trained phlebotomist collects 4 mL whole blood or bone marrow aspirate in a special EDTA tube, with strict cold-chain transport; we offer hospital-grade VIP mobile collection across the UAE from 8 AM to 11 PM.

3. When will I get my results, and how are they interpreted?

Results are delivered within 7 working days via a secure online portal; a DHA-licensed Consultant Medical Genetics can provide a telephonic guidance session to explain donor percentage and its clinical meaning in your context.

UAE Regulatory & Data Privacy Adherence

This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Our laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and operates under DHA Facility License No. 1143.

Clinical & Logistical Metadata

Test Name	Chimerism Post-Engraftment Analysis (STR-PCR, Blood)
Price (AED)	1,100 AED
Turnaround Time	7 working days
Sample Type / Matrix	Whole Blood (EDTA), Bone Marrow Aspirate
Methodology Used	Multiplex PCR-STR Fragment Analysis by Capillary Electrophoresis
ICD-10-CM Code	Z94.0 (Bone marrow transplant status), Z94.80 (Stem cell transplant status)
LOINC Code	53759-8 (Chimerism panel - STR, Blood)
DHA Facility License & Laboratory Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE